Association of Helicobacter pylori with Chronic Kidney Diseases: A Meta-Analysis

作者：Wijarnpreecha Karn^*; Thongprayoon Charat; Nissaisorakarn Pitchaphon; Jaruvongvanich Veeravich; Nakkala Kiran; Rajapakse Ridhmi; Cheungpasit**** Wisit

来源：Digestive Diseases and Sciences, 2017, 62(8): 2045-2052.

DOI：10.1007/s10620-017-4516-z

• Helicobacter pylori
• Campylobacter Chronic kidney disease
• Renal disease
• Meta-analysis

The reported risk of chronic kidney disease (CKD) in patients with Helicobacter pylori infection is conflicting. This meta-analysis was conducted to summarize all available data and to estimate the prevalence and association between H. pylori and kidney disease and CKD.
Comprehensive literature review was conducted using MEDLINE and EMBASE database through October 2016 to identify studies that reported the prevalence or the association between H. pylori infection and non-dialysis-dependent kidney diseases or CKD. Effect estimates from the individual study were extracted and combined using random-effect, generic inverse variance method of DerSimonian and Laird.
Of 4546 studies, nine cross-sectional studies met the eligibility criteria and were included in the meta-analysis. The estimated prevalence of H. pylori infection among subjects with kidney disease was 53% (95% CI 45-61%). The pooled OR of H. pylori in patients with non-dialysis-dependent kidney diseases was 1.20 (95% CI 0.73-1.97) when compared with the patients without kidney diseases. The meta-analysis was then limited to only studies evaluating the risk of H. pylori in CKD; the pooled OR of H. pylori in patients with CKD was 1.00 (95% CI 0.58-1.71).
The estimated prevalence of H. pylori in patients with non-dialysis-dependent kidney diseases is 53%. This study does not support the association between H. pylori infection and non-dialysis-dependent kidney diseases nor CKD.

• 出版日期2017-8